Shire Heritage in Haemophilia
The Shire Pipeline

Our Pursuit of a Robust Pipeline for Bleeding Conditions

Shire's relentless focus on bleeding conditions is evident in the investment we make into our research programs. In addition to our Research and Development pipeline, we support and collaborate on a number of studies that will enhance our understanding of the mechanism ofand risk factors forinhibitor development.

Continuous Innovation in Haemophilia Management

Shire is making extensive life cycle investments to optimise use of prophylaxis and develop new technologies to meet the current and future needs of the global haemophilia community.

Inhibitor Management

Shire is also supporting research designed to understand the aetiology of inhibitor development.

Exploring Management of Other Bleeding Conditions

Shire is also investing in the research of treatments for other bleeding conditions.

You are about to enter BaxaltaHematology.com
for healthcare professionals

You must be a certified healthcare professional to view this site. Click below to confirm that you are a certified healthcare professional.